| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 03/23/1999 | US5885967 Anticoagulants |
| 03/23/1999 | US5885959 Cyclic peptide compounds and their production process |
| 03/23/1999 | US5885958 Mu (morphine) opiate receptor; used in pharmaceuticals for providing analesia, treatment of gastrointestinal disorders, and therapy for drug dependence |
| 03/23/1999 | US5885782 Microbiocide oligopeptide mixture comprising at least two amino acid sequences; fungicides for treating plant or human |
| 03/23/1999 | CA2247735A1 Novel 5-membered ring heterocycles, their preparation, their use and pharmaceutical preparations comprising them |
| 03/23/1999 | CA2025858C Antihepatopathic composition |
| 03/18/1999 | WO1999012970A1 Peptides containing an arginine mimetic for the treatment of bone metabolic disorders, their production, and drugs containing these compounds |
| 03/18/1999 | WO1999012957A1 BASIC SALTS OF N-[N-(3,3-DIMETHYLBUTYL)-L-α-ASPARTYL]-L-PHE NYLALANINE 1-METHYL ESTER |
| 03/18/1999 | WO1999012956A1 ACID SALTS OF N-[N-(3,3-DIMETHYLBUTYL)-L-α-ASPARTYL]-L-PHENYLALANINE 1-METHYL ESTER |
| 03/18/1999 | WO1999012955A1 METAL COMPLEXES OF N-[N-(3,3-DIMETHYLBUTYL) -L-α-ASPARTYL]-L-PHENYLALANINE 1-METHYL ESTER |
| 03/18/1999 | WO1999012954A1 SWEETENER SALTS OF N-[N-(3,3-DIMETHYLBUTYL) -L-α-ASPARTYL]-L-PHENYLALANINE 1-METHYL ESTER |
| 03/18/1999 | WO1998052619A3 Peptide-coated implants and methods for producing same |
| 03/18/1999 | CA2303436A1 Acid salts of n-[n-(3,3-dimethylbutyl)-l-.alpha.-aspartyl]-l-phenylalanine 1-methyl ester |
| 03/18/1999 | CA2303435A1 Basic salts of n-[n-(3,3-dimethylbutyl)-l-.alpha.-aspartyl]-l-phenylala nine 1-methyl ester |
| 03/18/1999 | CA2303434A1 Sweetener salts of n-[n-(3,3-dimethylbutyl) -l-.alpha.-aspartyl]-l-phenylalanine 1-methyl ester |
| 03/18/1999 | CA2303433A1 Metal complexes of n-[n-(3,3-dimethylbutyl) -l-.alpha.-aspartyl]-l-phenylalanine 1-methyl ester |
| 03/18/1999 | CA2301969A1 Peptides containing an arginine mimetic for the treatment of bone metabolic disorders, their production, and drugs containing these compounds |
| 03/18/1999 | CA2247551A1 Novel imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them |
| 03/17/1999 | EP0902036A1 Peptide containing an arginine mimetic for the treatment of osteoporosis, their production, and drugs containing these compounds |
| 03/17/1999 | EP0901628A1 Phosphotyrosine mimics and methods for identifying and using same |
| 03/17/1999 | EP0779076A4 Peptide, a method of obtaining it and a pharmaceutical compound based on it |
| 03/17/1999 | EP0675899B1 NOVEL INHIBITORS OF FACTOR Xa |
| 03/16/1999 | US5883107 Antithrombotic agents |
| 03/16/1999 | US5883077 Peptides aldehyde analogues |
| 03/16/1999 | US5882900 Culturing planobispora rosea or mutant under submerged conditions in nutrient medium supplemented with vitamin b12 or analog thereof |
| 03/16/1999 | CA2081891C Quinolizinone type compounds |
| 03/11/1999 | WO1999011659A1 Novel cyclic tetrapeptide derivatives and medicinal use thereof |
| 03/11/1999 | WO1999011658A1 Meta-benzamidine derivatives as serin protease inhibitors |
| 03/11/1999 | WO1999011657A1 1-amino-7-isoquinoline derivatives as serine protease inhibitors |
| 03/11/1999 | WO1999011606A2 Inhibitors of protein tyrosine phosphatase |
| 03/11/1999 | CA2302451A1 Novel cyclic tetrapeptide derivatives and pharmaceutical use thereof |
| 03/11/1999 | CA2298601A1 Inhibitors of protein tyrosine phosphatase |
| 03/10/1999 | EP0900791A1 Tetrazole derivatives and drugs containing the same as the active ingredient |
| 03/10/1999 | EP0900566A1 Novel tripeptide compounds and anti-aids drugs |
| 03/10/1999 | EP0900384A2 Novel treatment |
| 03/10/1999 | EP0900231A1 Flea protease proteins, nucleic acid molecules, and uses thereof |
| 03/10/1999 | CN1210542A (N)-(3,3-dimethylbutyl)-L-aspartyl-D-'alpha' aminoalkanoic acid (N)-(S)-1-phenyl-1-alkanamide |
| 03/09/1999 | US5880259 Peptide useful as a ligand |
| 03/09/1999 | US5880125 4-spiroindoline piperidines promote release of growth hormone |
| 03/09/1999 | US5880119 Angiotensin converting enzyme inhibitors; analgesics, hypotensive agents, diuretics; treating congestive heart failure, irritable bowel syndrome |
| 03/09/1999 | US5880097 Tethered prodrugs |
| 03/09/1999 | US5880092 Conformationally stabilized cell adhesion peptides |
| 03/09/1999 | US5879658 Technetium-99m labeled peptides for thrombus imaging |
| 03/09/1999 | US5879657 Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders |
| 03/04/1999 | WO1999010374A1 Cyclosporin a conjugates and uses therefor |
| 03/04/1999 | WO1999010373A1 Non-immunosuppressive cyclosporins and their use in the prevention and treatment of hiv infection |
| 03/04/1999 | WO1999010372A1 Molecular mimetics of meningococcal b epitopes |
| 03/04/1999 | WO1999010371A2 Cyclopeptide derivatives as adhesion inhibitors |
| 03/04/1999 | WO1999009991A1 Novel amide derivatives |
| 03/04/1999 | WO1999009977A1 1,2,5-thiadiazolidin-3-one 1,1-dioxide derivatives |
| 03/04/1999 | CA2301566A1 N-acylated lipophilic amino acid derivatives |
| 03/04/1999 | CA2301182A1 Cyclopeptide derivatives |
| 03/03/1999 | EP0745080B1 Novel mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace |
| 03/02/1999 | US5877313 Benzo-fused azepinone and piperidinone compounds useful in the inhibition of ACE and NEP |
| 03/02/1999 | US5877297 Boronic compound complexing reagents and highly stable complexes |
| 03/02/1999 | US5877220 Delivering macromolecules to cells |
| 03/02/1999 | US5877197 C-terminal modified (N-substituted)-2-indolyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases |
| 03/02/1999 | US5877174 2,3-diketopiperazine derivatives or their salts |
| 03/02/1999 | US5877156 Cardiovascular disorders |
| 03/02/1999 | US5876748 Drug delivery |
| 03/02/1999 | US5876747 Liposome preferentially traveling to cardiac and skeletal muscles |
| 03/02/1999 | US5876712 Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated |
| 02/25/1999 | WO1999009056A1 Inhibition of hiv-1 replication using d-amino acid peptides |
| 02/25/1999 | WO1999009053A1 Phenethylamine derivatives |
| 02/25/1999 | WO1999008699A1 Growth hormone secretagogues |
| 02/25/1999 | DE19736772A1 New guanidino-substituted bi:cyclic peptide compounds |
| 02/25/1999 | CA2302467A1 Growth hormone secretagogues |
| 02/25/1999 | CA2301687A1 Phenethylamine derivatives |
| 02/24/1999 | EP0897392A1 Isolation and use of sh3 binding peptides |
| 02/24/1999 | CN1209139A Prodrugs of thrombin inhibitors |
| 02/23/1999 | US5874609 Process for crystallizing L-α-aspartyl-L-phenylanlanine methyl ester |
| 02/23/1999 | US5874585 Substituted heterocyclic compounds useful as inhibitors of (serine proteases) human neutrophil elastase |
| 02/23/1999 | US5874468 Brain targeted low molecular weight hydrophobic antioxidant compounds |
| 02/23/1999 | US5874424 Inhibitors of interleukin-1β converting enzyme |
| 02/23/1999 | US5874423 Cardiotonic agent |
| 02/23/1999 | US5874218 Method for detecting a target compound in a substance using a nucleic acid ligand |
| 02/23/1999 | US5874121 Method of producing L-aspartyl-D-alanine-N-(thiethane-3-yl)-amides |
| 02/18/1999 | WO1999007874A1 Process for producing lh-rh derivatives |
| 02/18/1999 | WO1999007733A2 Hepatitis c inhibitor peptides |
| 02/18/1999 | WO1999007732A1 SELECTIVE FACTOR Xa INHIBITORS |
| 02/18/1999 | WO1999007731A1 SELECTIVE FACTOR Xa INHIBITORS |
| 02/18/1999 | WO1999007730A1 SELECTIVE FACTOR Xa INHIBITORS CONTAINING A FUSED AZEPINONE STRUCTURE |
| 02/18/1999 | WO1999007729A2 Peptides having potassium channel opener activity |
| 02/18/1999 | WO1999007403A1 Nootropic drugs |
| 02/18/1999 | WO1998049190A3 Substituted oxadiazole cysteine protease inhibitors |
| 02/18/1999 | WO1998014593A3 Human telomerase catalytic subunit |
| 02/18/1999 | CA2301669A1 Peptides having potassium channel opener activity |
| 02/18/1999 | CA2300478A1 Selective factor xa inhibitors |
| 02/18/1999 | CA2299612A1 Selective factor xa inhibitors containing a fused azepinone structure |
| 02/18/1999 | CA2299610A1 Selective factor xa inhibitors |
| 02/18/1999 | CA2294049A1 Hepatitis c inhibitor peptides |
| 02/17/1999 | EP0896580A1 Specific immunophilin ligands as antiasthmatics and immunosuppressants |
| 02/16/1999 | US5872299 Method of preparing intermediates for retroviral protease inhibitors |
| 02/16/1999 | US5872298 Method of preparing intermediates for retroviral protease inhibitors |
| 02/16/1999 | US5872251 Process for preparing intermediates of inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof |
| 02/16/1999 | US5872224 Boronic compound complexing reagents and highly stable complexes |
| 02/16/1999 | US5872210 Used in the treatment of virally infected cells, in the preparation of vaccine formulations, in the generation of clinically relevant antibodies and anti-idiotypic antibodies and in the generation of a screening assay or kit that can be |
| 02/16/1999 | US5872146 Metalloproteinases involved in connective tissue breakdown, such as collagenase, stromelysin and gelatinase and tumor necrosis factor |
| 02/16/1999 | US5872135 Enzyme inhibitors |
| 02/16/1999 | US5872122 Pyrimidinylamidino β-amino acid derivatives useful as inhibitors of platelet aggregation |